Today's Top Stories


Hot Topics


Comment & Analysis »

GBI Research

The likely relocation of the EMA is bad news for the pharmaceutical industry and the health of 500 million Europeans

The likely relocation of the EMA is bad news for the pharmaceutical industry and the health of 500 million Europeans
GlobalData Healthcare

Researchers raise hope for affordable malaria diagnostics

Researchers raise hope for affordable malaria diagnostics
GlobalData Healthcare

Agios’s enasidenib is on track to become the first IDH2 inhibitor approved in AML

Agios’s enasidenib is on track to become the first IDH2 inhibitor approved in AML
GlobalData Healthcare

World Malaria Day 2017: focus on prevention

World Malaria Day 2017: focus on prevention
GlobalData Healthcare

23andMe: bringing early diagnosis of Type 1 Gaucher disease one step closer?

23andMe: bringing early diagnosis of Type 1 Gaucher disease one step closer?

Company Releases »

Avoiding the Supply Risk From Serialisation With CMOs

Be4ward
Avoiding the Supply Risk From Serialisation With CMOs

Stability Characterisation Using Differential Scanning Calorimetry

Malvern Instruments
Stability Characterisation Using Differential Scanning Calorimetry

How to Boost Profits With Single-Use Powder Transfer

ILC Dover How to Boost Profits With Single-Use Powder Transfer

DF30 Metering Valve Technology Platform for Drug Delivery

Aptar Pharma
DF30 Metering Valve Technology Platform for Drug Delivery

Seven Criteria for Evaluating Thermal Packaging Solutions

Cedarlane Shipping Supplies Seven Criteria for Evaluating Thermal Packaging Solutions

Pharmaceutical Insights »

Pharmaceutical Industry Reports »

Will competitive US pricing be enough to give Valeant’s Siliq an edge?

Will competitive US pricing be enough to give Valeant’s Siliq an edge?

Licensing deals in Duchenne Muscular Dystrophy (DMD)

Licensing deals in Duchenne Muscular Dystrophy (DMD)

China shows leading emerging market growth in R&D spend

China shows leading emerging market growth in R&D spend

Top sponsors and CROs for 2012-2016 clinical trials in Israel

Top sponsors and CROs for 2012-2016 clinical trials in Israel








cachename:HomePagecachekey:rd-1665407042_1729060782_rd-488908060_1460672566_ap1460672566_1729060782_-1100201212